S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
BBOT$2.33+0.87%
BridgeBio Oncology Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$186.81M
Float & O/S:
Inst Own:
DilutionScan read 49 of BridgeBio Oncology Therapeutics, Inc.'s SEC filings and found 1 convertible, 1 ATM program, 2 shelf registrations and 1 S-1 registration on file for BBOT. The latest dilution event on file is a registration statement on Sep 10, 2026. Analysis updated Nov 1, 2026.
Signal8 Summary
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 54 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 10, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Issued 2026
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
POS AM shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Know who's about to sell into your BBOT trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
